A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms

Clinical trial NCT07629726 · RECRUITING

Trial details

NCT number: NCT07629726
Sponsor: Kyowa Kirin Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematologic Neoplasms

Start date: 2026-08-01
Primary completion: 2027-04-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.